In 32 adults with bipolar I or II depression, adjunctive mixed amphetamine salt gave a 62.3% mean MADRS reduction vs 15.4% with placebo (P=.002); remission 63.3% vs 8.5%. Mania scores did not differ; one switch to mania in open-label.
RCTn = 32
Frye et al. Eight-Week Randomized, Double-Blind, Placebo-Controlled 2-Site Trial Assessing the Efficacy and Safety of Mixed Amphetamine Salt as an Adjunctive Therapy for Bipolar Depression